Skip to content

The Effect of femoral block on IV anesthetic consumption and analgesia during anesthesia and post operation

The Effect of perineural administration of dexmedetomidine on propofol and narcotic consumption and pain intensity in the patients undergoing femoral shaft fracture surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201204309593N1
Enrollment
60
Registered
2015-11-20
Start date
2014-11-18
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoral shaft fracture. Fracture of shaft of femur

Interventions

Intervention 1: In this Clinical Trail perineural administration of dexmedetomidine, 100 µg, was done before anesthesia. Intervention 2: In the control group anesthesia was done without perineural adm
Treatment - Drugs
Treatment - Surgery
In this Clinical Trail perineural administration of dexmedetomidine, 100 µg, was done before anesthesia.
In the control group anesthesia was done without perineural administration of dexmedetomidine and surgery was done.

Sponsors

anesthesiology research centre,shahid beheshti university of medical sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Exclusion criteria: allergy to an a2-adrenergic agonist or to one of the drugs used during the study; atracurium; propofol; morphine; midazolam; dexmedetomidine; lidocaine and fentanyl; age <18 years, renal and hepatic failure; planned intraoperative use of regional analgesia; addicted patients, treatment or consumption psychotropic medication or an opioid agonist or antagonist in the 24 hours before surgery; treatment with a2-adrenergic agonist or antagonist; ASA physical status III–IV patients; and patient less or more than 40 and 100 kg weight, respectively. Inclusion criteria: all patients with an elective femoral shaft fracture who had not exclusion criteria and their surgery duration was less than 3 hours were included in the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Propofol consumption. Timepoint: during 3 hour intraoparative. Method of measurement: propofol consumption.;Pain intensity. Timepoint: during 3 hour intraoparative and 6, 12, and 24 hour postoperative. Method of measurement: visual measurment.

Secondary

MeasureTime frame
Narcotic consumption. Timepoint: 1, 2 and 3 hours intra-operative and 24 hour postoperative. Method of measurement: consumpted drug.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElham Memari

Shahid Beheshti University of Medical Sciences

drmemary@gmail.com+98 21 7755 8082

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026